Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition: InfluenzaIntervention: Biological: VAX161-01C vaccineSponsor: VaxInnate CorporationCompleted - verified May 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | H5N1 | Influenza | Influenza Vaccine | Research | Study | Vaccines